Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
Some people may need slower dose increases or lower doses overall, depending on how they tolerate the medication
T.JohnstonW.Carda-DiguezM.SimpsonA.Cabello-YevesE.PielaK.et al
USA 96 , 1015210157 (1999)
Suglinge sind ferner NIE Veganer, da sie auf Muttermilch angewiesen sind, die bekanntlich nicht vegan ist, sondern von einem nicht-pflanzlichen Lebewesen stammt
Jakafi (ruxolitinib) Indication(s): Intermediate or highrisk myelofibrosis, polycythemia vera (after hydroxyurea failure), acute graftversushost disease (GVHD) and chronic GVHD in adults (and pediatric patients 12 years and older) Manufacturer(s): Incyte (in the US)/Novartis 2024 Sales: $4.73 billion Why it sold so well: Jakafi generated approximately $2.8 billion in sales in 2024, marking a solid 8% YoY increase
US$ 20.21
US$ 22.64
US$ 25.84
US$ 25.33
US$ 27.98
US$ 21.71
US$ 25.28
US$ 25.31
US$ 22.50
US$ 26.52
US$ 28.43
